Trial
NCT00468442
B-Lymphocyte Immunotherapy in Islet Transplantation
Phase IITERMINATEDEFFICACY/FUTILITYConfidence: MEDIUM
Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Collaborators
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Condition
Type 1 Diabetes Mellitus
Intervention
Allogeneic Pancreatic Islet Cells
Why stopped
Lack of efficacy
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2016-03-21